Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Non-Current Deffered Revenue (2022 - 2024)

Praxis Precision Medicines (PRAX) posted Non-Current Deffered Revenue of $293000.0 for Q3 2024, down 50.17% on a QoQ basis from $588000.0 in Q2 2024, and down 80.67% year-over-year from $1.5 million in Q4 2023.

Analysis

Praxis Precision Medicines (PRAX) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends

Praxis Precision Medicines has reported Non-Current Deffered Revenue for 3 years, with the latest figure at $293000.0 in Q3 2024.

  • On a quarterly basis, Non-Current Deffered Revenue fell 80.67% year-over-year to $293000.0 in Q3 2024; TTM through Sep 2024 was $293000.0, a 80.67% decrease from a year earlier, with the FY2023 full-year figure at $1.2 million, down 46.79% from the prior year.
  • Non-Current Deffered Revenue was $293000.0 for Q3 2024 at Praxis Precision Medicines, down from $588000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $2.2 million in Q4 2022, with the low at $293000.0 in Q3 2024.
  • Average Non-Current Deffered Revenue over 3 years is $1.2 million, with a median of $1.3 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue slumped 46.79% in 2023, then slumped 80.67% in 2024.
  • Over 3 years, Non-Current Deffered Revenue stood at $2.2 million in 2022, then slumped by 46.79% to $1.2 million in 2023, then tumbled by 74.76% to $293000.0 in 2024.
  • The last three Non-Current Deffered Revenue figures came in at $293000.0 (Q3 2024), $588000.0 (Q2 2024), and $866000.0 (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn -
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 220.40 Mn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 147.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn -
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn -
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 293,000.00
Jun 30, 2024 588,000.00
Mar 31, 2024 866,000.00
Dec 31, 2023 1.16 Mn
Sep 30, 2023 1.52 Mn
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.77 Mn
Dec 31, 2022 2.18 Mn
API Access

Praxis Precision Medicines Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PRAX&period=max&api_key=YOUR_API_KEY